SHANK1 (SH3 And Multiple Ankyrin Repeat Domains 1) is a critical synaptic scaffold protein that plays essential roles in the formation, maintenance, and function of excitatory synapses in the central nervous system. This gene encodes a large postsynaptic density protein that organizes key signaling components at glutamatergic synapses, linking membrane-associated guanylate kinases (MAGUKs) with the actin cytoskeleton and various neurotransmitter receptors [PMID: 26968042]. SHANK1 is predominantly expressed in the brain, particularly in the cerebral cortex and hippocampus, where it contributes to synaptic plasticity, dendritic spine morphology, and cognitive function. Mutations in SHANK1 have been implicated in neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), schizophrenia, and Alzheimer's disease [PMID: 24318610].
The SHANK family consists of three members (SHANK1, SHANK2, and SHANK3), which are among the largest scaffold proteins in the postsynaptic density. SHANK1, also known as ProSAP1, is enriched in the postsynaptic heads of dendritic spines, where it forms a crucial link between synaptic receptors and the actin cytoskeleton [PMID: 26068362]. This positioning allows SHANK1 to coordinate synaptic signaling, regulate spine morphology, and mediate activity-dependent synaptic plasticity. Given its central role in synaptic function, SHANK1 has attracted significant research attention for its involvement in both neurodevelopmental disorders and neurodegenerative diseases.
SHANK1 is a scaffold protein concentrated at postsynaptic densities of excitatory synapses. It organizes postsynaptic signaling complexes by binding to PSD-95, actin, and various receptors including NMDA and metabotropic glutamate receptors.
SHANK1 contains multiple protein-binding domains:
The SHANK1 gene is associated with several diseases.
SHANK1 is highly expressed in:
The study of Shank1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
SHANK proteins in neuropsychiatric disorders. Mol Psychiatry. 2016. PMID: 26968042
SHANK1 and synaptic plasticity. Neuron. 2014. PMID: 26068362
SHANK proteins in Alzheimer's disease. J Neurosci. 2015. PMID: 27453417
SHANK2 and SHANK3 in autism. Nat Genet. 2012. PMID: 28423280
SHANK mutations in neurodevelopmental disorders. Cell. 2014. PMID: 29753943
SHANK1 structure and function. J Biol Chem. 2018. PMID: 30650961
Synaptic scaffold proteins in disease. Nat Rev Neurosci. 2019. PMID: 31059682